Search research articles
Contact Us
Filters
Showing results (61-70 of 234) with videos related to
Page
of 24
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 12, 2012
Long-term dynamics of bone mineral density during intermittent androgen deprivation for men with nonmetastatic, hormone-sensitive prostate cancer
Evan Y Yu, Kevin F Kuo, Roman Gulati, et al.
European Urology Open Science
|
January 5, 2023
Surrogate Endpoints as Predictors of Overall Survival in Metastatic Urothelial Cancer: A Trial-level Analysis
Fady Ghali, Yibai Zhao, Devin Patel, et al.
European Urology
|
June 18, 2024
Docetaxel and Carboplatin for the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer and Biallelic Inactivation of Genes in the Homologous Recombination DNA Repair Pathway: The ABCD Trial
Ruben Raychaudhuri, Makayla DeJong, Matthew Rettig, et al.
JAMA Oncology
|
June 4, 2021
Concordance of DNA Repair Gene Mutations in Paired Primary Prostate Cancer Samples and Metastatic Tissue or Cell-Free DNA
Michael T Schweizer, Smruthy Sivakumar, Hanna Tukachinsky, et al.
European Urology Focus
|
December 7, 2025
Clinical Trial in Progress: SWOG S2210, a Phase 2 Study of Neoadjuvant Carboplatin for Localized High-risk Prostate Cancer with Germline BRCA1/2 Mutations
Heather H Cheng, Sam Callis, Evan Y Yu, et al.
Clinical Nuclear Medicine
|
February 3, 2011
C11-acetate and F-18 FDG PET for men with prostate cancer bone metastases: relative findings and response to therapy
Evan Y Yu, Mark Muzi, Joy A Hackenbracht, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 4, 2020
Complexities of Next-Generation Sequencing in Solid Tumors: Case Studies
Alexandra O Sokolova, Brian H Shirts, Eric Q Konnick, et al.
The Prostate
|
December 20, 2016
Clinical Correlates of Benefit From Radium-223 Therapy in Metastatic Castration Resistant Prostate Cancer
Ajjai Alva, Luke Nordquist, Stephanie Daignault, et al.
The Prostate
|
June 22, 2016
A Pilot Study of Clinical Targeted Next Generation Sequencing for Prostate Cancer: Consequences for Treatment and Genetic Counseling
Heather H Cheng, Nola Klemfuss, Bruce Montgomery, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 25, 2010
Randomized phase II study of docetaxel and prednisone with or without OGX-011 in patients with metastatic castration-resistant prostate cancer
Kim N Chi, Sebastien J Hotte, Evan Y Yu, et al.
Page
of 24
Search research articles
Search
Showing results (61-70 of 234) with videos related to
Sort By:
Page
of 24
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 12, 2012
Long-term dynamics of bone mineral density during intermittent androgen deprivation for men with nonmetastatic, hormone-sensitive prostate cancer
Evan Y Yu, Kevin F Kuo, Roman Gulati, et al.
European Urology Open Science
|
January 5, 2023
Surrogate Endpoints as Predictors of Overall Survival in Metastatic Urothelial Cancer: A Trial-level Analysis
Fady Ghali, Yibai Zhao, Devin Patel, et al.
European Urology
|
June 18, 2024
Docetaxel and Carboplatin for the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer and Biallelic Inactivation of Genes in the Homologous Recombination DNA Repair Pathway: The ABCD Trial
Ruben Raychaudhuri, Makayla DeJong, Matthew Rettig, et al.
JAMA Oncology
|
June 4, 2021
Concordance of DNA Repair Gene Mutations in Paired Primary Prostate Cancer Samples and Metastatic Tissue or Cell-Free DNA
Michael T Schweizer, Smruthy Sivakumar, Hanna Tukachinsky, et al.
European Urology Focus
|
December 7, 2025
Clinical Trial in Progress: SWOG S2210, a Phase 2 Study of Neoadjuvant Carboplatin for Localized High-risk Prostate Cancer with Germline BRCA1/2 Mutations
Heather H Cheng, Sam Callis, Evan Y Yu, et al.
Clinical Nuclear Medicine
|
February 3, 2011
C11-acetate and F-18 FDG PET for men with prostate cancer bone metastases: relative findings and response to therapy
Evan Y Yu, Mark Muzi, Joy A Hackenbracht, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 4, 2020
Complexities of Next-Generation Sequencing in Solid Tumors: Case Studies
Alexandra O Sokolova, Brian H Shirts, Eric Q Konnick, et al.
The Prostate
|
December 20, 2016
Clinical Correlates of Benefit From Radium-223 Therapy in Metastatic Castration Resistant Prostate Cancer
Ajjai Alva, Luke Nordquist, Stephanie Daignault, et al.
The Prostate
|
June 22, 2016
A Pilot Study of Clinical Targeted Next Generation Sequencing for Prostate Cancer: Consequences for Treatment and Genetic Counseling
Heather H Cheng, Nola Klemfuss, Bruce Montgomery, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 25, 2010
Randomized phase II study of docetaxel and prednisone with or without OGX-011 in patients with metastatic castration-resistant prostate cancer
Kim N Chi, Sebastien J Hotte, Evan Y Yu, et al.
Page
of 24